Iona K Machado1, Paula M Luz2, Jordan E Lake3, Rodolfo Castro4, Luciane Velasque5, Jesse L Clark3, Valdilea G Veloso2, Beatriz Grinsztejn2, Raquel B De Boni2. 1. University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA; Columbia University College of Physicians & Surgeons, 630 W. 168th St., New York, NY 10032, USA. Electronic address: ionak.machado@gmail.com. 2. Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos Rio de Janeiro, RJ, Brazil. 3. University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA. 4. Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos Rio de Janeiro, RJ, Brazil; Universidade Federal do Estado do Rio de Janeiro, Avenida Pasteur 296, Urca Rio de Janeiro, RJ, Brazil. 5. Universidade Federal do Estado do Rio de Janeiro, Avenida Pasteur 296, Urca Rio de Janeiro, RJ, Brazil.
Abstract
BACKGROUND: Substance use assessment is a challenge in busy clinical settings that may adversely affect HIV-infected persons. This study aimed to evaluate agreement between the medical chart and a standardized substance use screening questionnaire. METHODS: Of adults (n=1050) in HIV care in Rio de Janeiro who completed the World Health Organization's Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), we randomly selected 200 participants for medical chart review. Lifetime use of tobacco, alcohol, marijuana, and cocaine agreement between the medical record and ASSIST was evaluated using Kappa statistics. Sensitivity and specificity of chart information were also calculated. RESULTS: The median age was 42.4 years, 60.3% were male and 49.5% were white. Prevalence of lifetime use reported in ASSIST was 55.3% (tobacco), 79.4% (alcohol), 23.1% (marijuana), and 20.7% (cocaine). Any information on lifetime use was found in the medical chart for tobacco (n=180, 90.5%), alcohol (n=183, 92.0%), marijuana (n=143, 71.8%), and cocaine (n=151, 75.9%). The Kappa statistic, sensitivity and specificity of the medical chart accurately identifying lifetime substance users per ASSIST were respectively 0.60, 0.71, and 0.91 for tobacco; 0.22, 0.75, and 0.51 for alcohol; 0.58, 0.51, and 0.98 for marijuana; and 0.73, 0.75, and 0.96 for cocaine. CONCLUSION: Considering inaccuracies in the medical chart, the implementation of brief, standardized substance use screening is recommended in HIV care settings.
BACKGROUND: Substance use assessment is a challenge in busy clinical settings that may adversely affect HIV-infectedpersons. This study aimed to evaluate agreement between the medical chart and a standardized substance use screening questionnaire. METHODS: Of adults (n=1050) in HIV care in Rio de Janeiro who completed the World Health Organization's Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST), we randomly selected 200 participants for medical chart review. Lifetime use of tobacco, alcohol, marijuana, and cocaine agreement between the medical record and ASSIST was evaluated using Kappa statistics. Sensitivity and specificity of chart information were also calculated. RESULTS: The median age was 42.4 years, 60.3% were male and 49.5% were white. Prevalence of lifetime use reported in ASSIST was 55.3% (tobacco), 79.4% (alcohol), 23.1% (marijuana), and 20.7% (cocaine). Any information on lifetime use was found in the medical chart for tobacco (n=180, 90.5%), alcohol (n=183, 92.0%), marijuana (n=143, 71.8%), and cocaine (n=151, 75.9%). The Kappa statistic, sensitivity and specificity of the medical chart accurately identifying lifetime substance users per ASSIST were respectively 0.60, 0.71, and 0.91 for tobacco; 0.22, 0.75, and 0.51 for alcohol; 0.58, 0.51, and 0.98 for marijuana; and 0.73, 0.75, and 0.96 for cocaine. CONCLUSION: Considering inaccuracies in the medical chart, the implementation of brief, standardized substance use screening is recommended in HIV care settings.
Authors: Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor Journal: Addiction Date: 2010-03-15 Impact factor: 6.526
Authors: Iona K Machado; Paula M Luz; Jordan E Lake; Rodolfo Castro; Luciane Velasque; Jesse L Clark; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni Journal: Int J STD AIDS Date: 2017-02-02 Impact factor: 1.359
Authors: P Todd Korthuis; Somnath Saha; Geetanjali Chander; Dennis McCarty; Richard D Moore; Jonathan A Cohn; Victoria L Sharp; Mary Catherine Beach Journal: AIDS Behav Date: 2011-05
Authors: Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore Journal: AIDS Date: 2009-10-23 Impact factor: 4.177
Authors: Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey Journal: AIDS Date: 2008-07-11 Impact factor: 4.177
Authors: R S Braithwaite; J Conigliaro; M S Roberts; S Shechter; A Schaefer; K McGinnis; M C Rodriguez; L Rabeneck; K Bryant; A C Justice Journal: AIDS Care Date: 2007-04
Authors: Philip Todd Korthuis; Joshua S Josephs; John A Fleishman; James Hellinger; Seth Himelhoch; Geetanjali Chander; Elizabeth B Morse; Kelly A Gebo Journal: J Subst Abuse Treat Date: 2008-03-07
Authors: Thiago S Torres; Paula M Luz; Monica Derrico; Luciane Velasque; Eduarda Grinsztejn; Valdiléa G Veloso; Sandra W Cardoso; Marília Santini-Oliveira; Beatriz Grinsztejn; Raquel Brandini De Boni Journal: PLoS One Date: 2014-12-23 Impact factor: 3.240
Authors: Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia Journal: Int J Environ Res Public Health Date: 2022-06-12 Impact factor: 4.614
Authors: Jessica P Ridgway; Arno Uvin; Jessica Schmitt; Tomasz Oliwa; Ellen Almirol; Samantha Devlin; John Schneider Journal: JMIR Med Inform Date: 2021-03-10